首页 > 最新文献

Current opinion in pediatrics最新文献

英文 中文
Updates on postinfectious skin rashes in pediatric dermatology. 儿科皮肤科感染后皮疹的最新进展。
IF 2.2 3区 医学 Q2 PEDIATRICS Pub Date : 2024-06-06 DOI: 10.1097/MOP.0000000000001376
Samantha Shwe Daniel, Caitlin Peterman, Smita Awasthi

Purpose of review: This review provides updates on postinfectious skin rashes in the pediatric population from recently published literature.

Recent findings: The COVID-19 pandemic and its sequelae remain a focus of research on pediatric infectious skin rashes. Multisystem inflammatory syndrome in children (MIS-C) and reactive infectious mucocutaneous eruption (RIME) are common complications of infection with SARS-COV-2 in the pediatric population. Most cases of MIS-C show low mortality and suggest mucocutaneous symptoms do not correlate with COVID-19 disease severity. Cases of papular acrodermatitis of childhood, also known as Gianotti-Crosti, have also been reported in association with SARS-COV-2, and can present similarly in reaction to other viral infection like molluscum contagiosum, known as a Gianotti-Crosti syndrome-like reaction (GCLR). Other relevant studies on postinfectious skin rashes include updates on the management of staphylococcal scalded skin syndrome (SSSS), with newer evidence advocating for beta-lactam monotherapy without clindamycin and reduced ancillary testing. Finally, the emergence of antifungal resistance due to Trichophyton indotinae is a growing global health concern emphasizing the need for improved antifungal stewardship.

Summary: It is prudent for clinicians to be informed of both common and rare diagnoses that have emerged more recently in association with the COVID-19 pandemic, in addition to other diseases with newer evidence-based recommendations to guide management.

综述目的:本综述从最近发表的文献中提供了有关儿科感染后皮疹的最新情况:COVID-19大流行及其后遗症仍然是儿科感染性皮疹的研究重点。儿童多系统炎症综合征(MIS-C)和反应性传染性粘膜糜烂(RIME)是儿科人群感染 SARS-COV-2 后常见的并发症。大多数 MIS-C 病例的死亡率较低,并表明粘膜症状与 COVID-19 疾病的严重程度无关。儿童丘疹性肢皮炎(又称 Gianotti-Crosti)病例也有与 SARS-COV-2 相关的报道,也可能出现与其他病毒感染(如传染性软疣)类似的反应,即 Gianotti-Crosti 综合征样反应(GCLR)。其他与感染后皮疹相关的研究还包括葡萄球菌烫伤皮肤综合征(SSSS)的最新治疗方法,最新的证据表明应采用β-内酰胺类单药治疗,不使用克林霉素,并减少辅助检查。最后,由茚满毛癣菌引起的抗真菌耐药性的出现是一个日益严重的全球健康问题,强调了改善抗真菌管理的必要性。总结:临床医生应该了解最近与 COVID-19 大流行相关的常见和罕见诊断,以及其他疾病的最新循证建议,以指导治疗。
{"title":"Updates on postinfectious skin rashes in pediatric dermatology.","authors":"Samantha Shwe Daniel, Caitlin Peterman, Smita Awasthi","doi":"10.1097/MOP.0000000000001376","DOIUrl":"10.1097/MOP.0000000000001376","url":null,"abstract":"<p><strong>Purpose of review: </strong>This review provides updates on postinfectious skin rashes in the pediatric population from recently published literature.</p><p><strong>Recent findings: </strong>The COVID-19 pandemic and its sequelae remain a focus of research on pediatric infectious skin rashes. Multisystem inflammatory syndrome in children (MIS-C) and reactive infectious mucocutaneous eruption (RIME) are common complications of infection with SARS-COV-2 in the pediatric population. Most cases of MIS-C show low mortality and suggest mucocutaneous symptoms do not correlate with COVID-19 disease severity. Cases of papular acrodermatitis of childhood, also known as Gianotti-Crosti, have also been reported in association with SARS-COV-2, and can present similarly in reaction to other viral infection like molluscum contagiosum, known as a Gianotti-Crosti syndrome-like reaction (GCLR). Other relevant studies on postinfectious skin rashes include updates on the management of staphylococcal scalded skin syndrome (SSSS), with newer evidence advocating for beta-lactam monotherapy without clindamycin and reduced ancillary testing. Finally, the emergence of antifungal resistance due to Trichophyton indotinae is a growing global health concern emphasizing the need for improved antifungal stewardship.</p><p><strong>Summary: </strong>It is prudent for clinicians to be informed of both common and rare diagnoses that have emerged more recently in association with the COVID-19 pandemic, in addition to other diseases with newer evidence-based recommendations to guide management.</p>","PeriodicalId":10985,"journal":{"name":"Current opinion in pediatrics","volume":null,"pages":null},"PeriodicalIF":2.2,"publicationDate":"2024-06-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141491216","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nevi - when to refer. Nevi - 何时转诊。
IF 2.2 3区 医学 Q2 PEDIATRICS Pub Date : 2024-06-05 DOI: 10.1097/MOP.0000000000001375
Saloni A Shah, Marla N Jahnke

Purpose of review: Congenital melanocytic nevi (CMN) and acquired nevi are prevalent in pediatric populations, with distinct characteristics and management considerations. This chapter aims to equip pediatricians with knowledge to discern between benign and high-risk nevi, facilitating appropriate referrals and management within primary care settings. Risk factors associated with malignant melanoma (MM) underscore the importance of vigilant monitoring and early referral to dermatology for suspicious lesions.

Recent findings: Recent findings highlight the variability in CMN presentation and the evolving diagnostic strategies, emphasizing the need for multidisciplinary approaches to optimize patient outcomes.

Summary: Management of CMN involves tailored surveillance and intervention strategies, with an emphasis on early identification of high-risk features for MM and neurocutaneous melanosis (NCM). Pediatricians play a crucial role in advocating for sun protection practices and facilitating timely referrals, thereby contributing to the overall well being of pediatric patients with nevi.

综述目的:先天性黑素细胞痣(CMN)和后天性黑素细胞痣在儿科人群中很常见,它们具有不同的特征和管理注意事项。本章旨在让儿科医生掌握辨别良性痣和高危痣的知识,以便在初级医疗机构中进行适当的转诊和管理。与恶性黑色素瘤(MM)相关的风险因素强调了对可疑病变进行警惕性监测并及早转诊至皮肤科的重要性:小结:CMN 的管理涉及有针对性的监测和干预策略,重点是早期识别 MM 和神经皮肤黑变病(NCM)的高危特征。儿科医生在倡导防晒措施和促进及时转诊方面发挥着至关重要的作用,从而为患有痣的儿科患者的整体健康做出贡献。
{"title":"Nevi - when to refer.","authors":"Saloni A Shah, Marla N Jahnke","doi":"10.1097/MOP.0000000000001375","DOIUrl":"10.1097/MOP.0000000000001375","url":null,"abstract":"<p><strong>Purpose of review: </strong>Congenital melanocytic nevi (CMN) and acquired nevi are prevalent in pediatric populations, with distinct characteristics and management considerations. This chapter aims to equip pediatricians with knowledge to discern between benign and high-risk nevi, facilitating appropriate referrals and management within primary care settings. Risk factors associated with malignant melanoma (MM) underscore the importance of vigilant monitoring and early referral to dermatology for suspicious lesions.</p><p><strong>Recent findings: </strong>Recent findings highlight the variability in CMN presentation and the evolving diagnostic strategies, emphasizing the need for multidisciplinary approaches to optimize patient outcomes.</p><p><strong>Summary: </strong>Management of CMN involves tailored surveillance and intervention strategies, with an emphasis on early identification of high-risk features for MM and neurocutaneous melanosis (NCM). Pediatricians play a crucial role in advocating for sun protection practices and facilitating timely referrals, thereby contributing to the overall well being of pediatric patients with nevi.</p>","PeriodicalId":10985,"journal":{"name":"Current opinion in pediatrics","volume":null,"pages":null},"PeriodicalIF":2.2,"publicationDate":"2024-06-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141491211","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Highly effective cystic fibrosis transmembrane conductance (regulator) modulator therapy: shifting the curve for most while leaving some further behind. 高效囊性纤维化跨膜传导(调节)调节器疗法:改变了大多数人的治疗曲线,却让一些人落在后面。
IF 3.6 3区 医学 Q1 Medicine Pub Date : 2024-06-01 Epub Date: 2024-02-15 DOI: 10.1097/MOP.0000000000001338
Stanford W Chun, Maya E Somers, Elizabeth B Burgener

Purpose of review: Traditional cystic fibrosis (CF) care had been focused on early intervention and symptom mitigation. With the advent of highly effective cystic fibrosis transmembrane conductance regulator (CFTR) modulator therapy (HEMT), in particular, the approval of elexacaftor/tezacaftor/ivacaftor in 2019, there has been a dramatic improvement in outcomes in CF. The purpose of this article is to review the benefits, limitations, and impact of HEMT as well as discuss the new implications, challenges, and hope that modulators bring to people with CF (pwCF).

Recent findings: HEMT has demonstrated sustained improvement in lung function, nutrition, quality of life, and survival for over 90% of pwCF. As HEMT has delivered such promise, there is a small but significant portion of pwCF who do not benefit from HEMT due to ineligible mutations, intolerance, or lack of accessibility to modulators.

Summary: HEMT has significantly improved outcomes, but continued research is needed to understand the new challenges and implications the era of HEMT will bring, as well as how to provide equitable care to those who are unable to benefit from HEMT.

审查目的:传统的囊性纤维化(CF)治疗侧重于早期干预和减轻症状。随着高效囊性纤维化跨膜传导调节剂(CFTR)调节剂疗法(HEMT)的出现,特别是2019年elexacaftor/tezacaftor/ivacaftor的批准,CF的治疗效果有了显著改善。本文旨在回顾 HEMT 的益处、局限性和影响,并讨论调制剂给 CF 患者(pwCF)带来的新影响、挑战和希望:最近的研究结果:HEMT 已证明可持续改善 90% 以上 CF 患者的肺功能、营养、生活质量和存活率。摘要:HEMT 显著改善了治疗效果,但仍需继续研究,以了解 HEMT 时代将带来的新挑战和新影响,以及如何为无法从 HEMT 中受益的患者提供公平的治疗。
{"title":"Highly effective cystic fibrosis transmembrane conductance (regulator) modulator therapy: shifting the curve for most while leaving some further behind.","authors":"Stanford W Chun, Maya E Somers, Elizabeth B Burgener","doi":"10.1097/MOP.0000000000001338","DOIUrl":"10.1097/MOP.0000000000001338","url":null,"abstract":"<p><strong>Purpose of review: </strong>Traditional cystic fibrosis (CF) care had been focused on early intervention and symptom mitigation. With the advent of highly effective cystic fibrosis transmembrane conductance regulator (CFTR) modulator therapy (HEMT), in particular, the approval of elexacaftor/tezacaftor/ivacaftor in 2019, there has been a dramatic improvement in outcomes in CF. The purpose of this article is to review the benefits, limitations, and impact of HEMT as well as discuss the new implications, challenges, and hope that modulators bring to people with CF (pwCF).</p><p><strong>Recent findings: </strong>HEMT has demonstrated sustained improvement in lung function, nutrition, quality of life, and survival for over 90% of pwCF. As HEMT has delivered such promise, there is a small but significant portion of pwCF who do not benefit from HEMT due to ineligible mutations, intolerance, or lack of accessibility to modulators.</p><p><strong>Summary: </strong>HEMT has significantly improved outcomes, but continued research is needed to understand the new challenges and implications the era of HEMT will bring, as well as how to provide equitable care to those who are unable to benefit from HEMT.</p>","PeriodicalId":10985,"journal":{"name":"Current opinion in pediatrics","volume":null,"pages":null},"PeriodicalIF":3.6,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11042992/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139971328","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Resuscitating the macro- vs. microcirculation in septic shock. 抢救脓毒性休克的大循环与微循环。
IF 3.6 3区 医学 Q1 Medicine Pub Date : 2024-06-01 Epub Date: 2024-03-04 DOI: 10.1097/MOP.0000000000001345
Rafael González, Javier Urbano, Jesús López-Herce

Purpose of review: This review summarizes current literature about the relationships between macro and microcirculation and their practical clinical implications in children with septic shock.

Recent findings: Current evidence from experimental and clinical observational studies in children and adults with septic shock reveals that the response to treatment and resuscitation is widely variable. Furthermore, there is a loss of hemodynamic coherence, as resuscitation-induced improvement in macrocirculation (systemic hemodynamic parameters) does not necessarily result in a parallel improvement in the microcirculation. Therefore, patient-tailored monitoring is essential in order to adjust treatment requirements during resuscitation in septic shock. Optimal monitoring must integrate macrocirculation (heart rate, blood pressure, cardiac output, and ultrasound images), microcirculation (videomicroscopy parameters and capillary refill time) and cellular metabolism (lactic acid, central venous blood oxygen saturation, and difference of central venous to arterial carbon dioxide partial pressure).

Summary: There is a dire need for high-quality studies to assess the relationships between macrocirculation, microcirculation and tissue metabolism in children with septic shock. The development of reliable and readily available microcirculation and tissue perfusion biomarkers (other than lactic acid) is also necessary to improve monitoring and treatment adjustment in such patients.

综述的目的:本综述总结了目前有关脓毒性休克患儿大循环和微循环之间的关系及其实际临床意义的文献:最近的研究结果:对脓毒性休克患儿和成人进行的实验和临床观察研究表明,治疗和复苏的反应千差万别。此外,由于复苏引起的大循环(全身血液动力学参数)改善并不一定导致微循环的同步改善,因此血液动力学失去了连贯性。因此,为了在脓毒性休克患者复苏期间调整治疗要求,针对患者的监测至关重要。最佳监测必须整合大循环(心率、血压、心输出量和超声图像)、微循环(视频显微镜参数和毛细血管再充盈时间)和细胞代谢(乳酸、中心静脉血氧饱和度和中心静脉与动脉二氧化碳分压差)。此外,还需要开发可靠且易于使用的微循环和组织灌注生物标志物(乳酸除外),以改善对此类患者的监测和治疗调整。
{"title":"Resuscitating the macro- vs. microcirculation in septic shock.","authors":"Rafael González, Javier Urbano, Jesús López-Herce","doi":"10.1097/MOP.0000000000001345","DOIUrl":"10.1097/MOP.0000000000001345","url":null,"abstract":"<p><strong>Purpose of review: </strong>This review summarizes current literature about the relationships between macro and microcirculation and their practical clinical implications in children with septic shock.</p><p><strong>Recent findings: </strong>Current evidence from experimental and clinical observational studies in children and adults with septic shock reveals that the response to treatment and resuscitation is widely variable. Furthermore, there is a loss of hemodynamic coherence, as resuscitation-induced improvement in macrocirculation (systemic hemodynamic parameters) does not necessarily result in a parallel improvement in the microcirculation. Therefore, patient-tailored monitoring is essential in order to adjust treatment requirements during resuscitation in septic shock. Optimal monitoring must integrate macrocirculation (heart rate, blood pressure, cardiac output, and ultrasound images), microcirculation (videomicroscopy parameters and capillary refill time) and cellular metabolism (lactic acid, central venous blood oxygen saturation, and difference of central venous to arterial carbon dioxide partial pressure).</p><p><strong>Summary: </strong>There is a dire need for high-quality studies to assess the relationships between macrocirculation, microcirculation and tissue metabolism in children with septic shock. The development of reliable and readily available microcirculation and tissue perfusion biomarkers (other than lactic acid) is also necessary to improve monitoring and treatment adjustment in such patients.</p>","PeriodicalId":10985,"journal":{"name":"Current opinion in pediatrics","volume":null,"pages":null},"PeriodicalIF":3.6,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140038923","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Precision care in the treatment of pediatric asthma. 治疗小儿哮喘的精准护理。
IF 3.6 3区 医学 Q1 Medicine Pub Date : 2024-06-01 Epub Date: 2024-02-23 DOI: 10.1097/MOP.0000000000001343
Lina Mahmood, Sevdenur Keskin, Akilah A Jefferson

Purpose of review: Precision medicine in pediatric asthma involves identification of asthma phenotypes, genetic markers, biomarkers, and biologics that target specific pathways. This review includes a discussion of the efficacy of currently approved biologics for pediatric asthma and most recent advances in biomarker/phenotype identification and genetic associations that affect asthma care.

Recent findings: Biologics targeting type-2 mediated pathways have shown success in the treatment of moderate to severe asthma in pediatric and adult patients. In comparative studies, dupilumab, an interleukin-4 (IL-4) alpha receptor inhibitor, and mepolizumab, an IL-5 inhibitor, have shown more improvement in asthma exacerbation rates and lung function compared to other biologics such as tezepelumab, omalizumab and benralizumab. Other methods used to categorize asthma treatment response have been investigated and include use of biomarkers such as fractional exhaled nitric oxide (FeNO). Genomic studies are also emerging in precision care for pediatric asthma.

Summary: An understanding of underlying immunologic and genetic mechanisms affecting the development of asthma in pediatric patients has resulted in the production of numerous targeted therapies that have led to improvement in lung function and reduced exacerbation burden.

综述目的:小儿哮喘的精准医疗涉及哮喘表型、遗传标记物、生物标记物和针对特定途径的生物制剂的识别。本综述讨论了目前已批准用于治疗小儿哮喘的生物制剂的疗效,以及生物标记物/表型鉴定和影响哮喘治疗的遗传关联方面的最新进展:针对 2 型介导途径的生物制剂在治疗儿童和成人中度至重度哮喘方面取得了成功。在比较研究中,白细胞介素-4(IL-4)α受体抑制剂dupilumab和IL-5抑制剂mepolizumab与其他生物制剂(如tezepelumab、omalizumab和benralizumab)相比,对哮喘恶化率和肺功能的改善更大。还研究了用于对哮喘治疗反应进行分类的其他方法,包括使用生物标志物,如呼气一氧化氮分数(FeNO)。基因组研究也正在儿科哮喘的精准治疗中崭露头角。摘要:随着对影响儿科哮喘发病的潜在免疫学和遗传学机制的了解,许多靶向疗法应运而生,从而改善了肺功能并减轻了病情恶化的负担。
{"title":"Precision care in the treatment of pediatric asthma.","authors":"Lina Mahmood, Sevdenur Keskin, Akilah A Jefferson","doi":"10.1097/MOP.0000000000001343","DOIUrl":"10.1097/MOP.0000000000001343","url":null,"abstract":"<p><strong>Purpose of review: </strong>Precision medicine in pediatric asthma involves identification of asthma phenotypes, genetic markers, biomarkers, and biologics that target specific pathways. This review includes a discussion of the efficacy of currently approved biologics for pediatric asthma and most recent advances in biomarker/phenotype identification and genetic associations that affect asthma care.</p><p><strong>Recent findings: </strong>Biologics targeting type-2 mediated pathways have shown success in the treatment of moderate to severe asthma in pediatric and adult patients. In comparative studies, dupilumab, an interleukin-4 (IL-4) alpha receptor inhibitor, and mepolizumab, an IL-5 inhibitor, have shown more improvement in asthma exacerbation rates and lung function compared to other biologics such as tezepelumab, omalizumab and benralizumab. Other methods used to categorize asthma treatment response have been investigated and include use of biomarkers such as fractional exhaled nitric oxide (FeNO). Genomic studies are also emerging in precision care for pediatric asthma.</p><p><strong>Summary: </strong>An understanding of underlying immunologic and genetic mechanisms affecting the development of asthma in pediatric patients has resulted in the production of numerous targeted therapies that have led to improvement in lung function and reduced exacerbation burden.</p>","PeriodicalId":10985,"journal":{"name":"Current opinion in pediatrics","volume":null,"pages":null},"PeriodicalIF":3.6,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11042999/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139971329","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Caring for screenagers (Part 1): a pediatrician's primer on popular social media platforms. 关爱屏幕少年(第一部分):儿科医生关于流行社交媒体平台的入门读物。
IF 3.6 3区 医学 Q1 Medicine Pub Date : 2024-06-01 Epub Date: 2024-03-05 DOI: 10.1097/MOP.0000000000001342
Grace Cason, Alex Margolis, Joseph Barile, Ruth Lynn Milanaik

Purpose of review: Since the inception of social media, children have used platforms in manners unbeknownst to their parents. Just when parents feel they may finally understand what platform is relevant or trend is "in," the landscape evolves, and children shift to something new. It is therefore critical that pediatricians stay informed about what is popular in youth populations. This enables the recognition of the potential dangers of contemporary social media engagement.

Recent findings: Short-form content and livestreaming continue to rise in popularity while certain older forms of social media have retained relevancy in youth circles. YouTube is the dominant social media force, with both livestreaming and short-form offerings. Twitch and TikTok provide alternatives to YouTube for livestreaming and short-form content, respectively. Instagram and Snapchat - two social media apps that have existed for over 10 years - remain as the most popular mechanisms for children to interact with their friends online.

Summary: Issues related to body image, attention deficits, cyberbullying, and other potential harms have many parents wary of their child's presence on social media. Social media sites have in-place mechanisms to prevent the likelihood of harm, but pediatricians and parents should still counsel children on best social media practices.

审查目的:自社交媒体诞生以来,孩子们一直在以父母不知道的方式使用这些平台。就在父母觉得他们终于明白什么平台是相关的或什么趋势是 "流行 "的时候,情况却发生了变化,孩子们转向了新的东西。因此,儿科医生必须随时了解青少年群体的流行趋势。这有助于认识到当代社交媒体参与的潜在危险:最近的研究结果:短篇内容和直播的受欢迎程度继续上升,而某些旧形式的社交媒体在青少年圈中仍保持着相关性。YouTube 是社交媒体的主导力量,提供直播和短视频内容。Twitch 和 TikTok 分别提供了替代 YouTube 的直播和短视频内容。Instagram和Snapchat这两个社交媒体应用程序已经存在了10多年,仍然是儿童与朋友进行在线互动的最流行机制。摘要:与身体形象、注意力缺陷、网络欺凌和其他潜在危害有关的问题让许多家长对孩子在社交媒体上的表现保持警惕。社交媒体网站有防止伤害发生的机制,但儿科医生和家长仍应就社交媒体的最佳做法向儿童提供咨询。
{"title":"Caring for screenagers (Part 1): a pediatrician's primer on popular social media platforms.","authors":"Grace Cason, Alex Margolis, Joseph Barile, Ruth Lynn Milanaik","doi":"10.1097/MOP.0000000000001342","DOIUrl":"10.1097/MOP.0000000000001342","url":null,"abstract":"<p><strong>Purpose of review: </strong>Since the inception of social media, children have used platforms in manners unbeknownst to their parents. Just when parents feel they may finally understand what platform is relevant or trend is \"in,\" the landscape evolves, and children shift to something new. It is therefore critical that pediatricians stay informed about what is popular in youth populations. This enables the recognition of the potential dangers of contemporary social media engagement.</p><p><strong>Recent findings: </strong>Short-form content and livestreaming continue to rise in popularity while certain older forms of social media have retained relevancy in youth circles. YouTube is the dominant social media force, with both livestreaming and short-form offerings. Twitch and TikTok provide alternatives to YouTube for livestreaming and short-form content, respectively. Instagram and Snapchat - two social media apps that have existed for over 10 years - remain as the most popular mechanisms for children to interact with their friends online.</p><p><strong>Summary: </strong>Issues related to body image, attention deficits, cyberbullying, and other potential harms have many parents wary of their child's presence on social media. Social media sites have in-place mechanisms to prevent the likelihood of harm, but pediatricians and parents should still counsel children on best social media practices.</p>","PeriodicalId":10985,"journal":{"name":"Current opinion in pediatrics","volume":null,"pages":null},"PeriodicalIF":3.6,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140038921","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Respiratory adenovirus infections in children: a focus on Africa. 儿童呼吸道腺病毒感染:聚焦非洲。
IF 3.6 3区 医学 Q1 Medicine Pub Date : 2024-06-01 Epub Date: 2024-02-29 DOI: 10.1097/MOP.0000000000001335
Marieke M van der Zalm, Nadia A Sam-Agudu, Lilly M Verhagen

Purpose of review: Lower respiratory tract infections (LRTIs) are an important cause of child morbidity and mortality globally, especially in children under the age of 5 years in Africa. Respiratory viruses, including human adenoviruses (HAdVs), are common causes of LRTIs in children. This review aims to shed light on the epidemiology, clinical manifestations, sequelae, and treatment options specific to adenovirus respiratory infections in African children.

Recent findings: Recent evidence has challenged the perception that adenovirus is a negligible cause of LRTIs. Studies show HAdV emerging as the third most common viral pathogen in fatal pneumonias among under-5 children in low-income and middle-income African countries, contributing to 5.5% of all pneumonia deaths and ranking second in hospital-associated viral pneumonia deaths. Predominant HAdV serotypes associated with disease differ by country and region, and have changed over time. Risk factors for increased disease severity and long-term respiratory sequelae in previously healthy African children with HAdV LRTIs are not well established.

Summary: Although respiratory viruses, including HAdV, are recognized contributors to LRTIs, the prevalence and impact of adenovirus infections have been under-recognized and understated. Available data suggests that African children, particularly those under 5 years old, are at risk of severe sequelae from respiratory HAdV infections. Long-term sequelae, including bronchiectasis and postinfectious bronchiolitis obliterans, further underscore the significant impact of HAdV infections. However, the scarcity of comprehensive data hampers our understanding of the extent of the impact of HAdV infections on child lung health in Africa. We recommend scaled-up HAdV surveillance, ensuring its consistent inclusion in population-level LRTI assessments, and expanded and equitable access to diagnostics for early recognition of African children at risk of developing chronic sequelae and death. Enhanced understanding of adenovirus epidemiology and clinical outcomes and the availability of therapeutic options are essential for informed public health strategies and clinical care.

审查目的:下呼吸道感染(LRTIs)是全球儿童发病和死亡的重要原因,尤其是非洲 5 岁以下儿童。包括人类腺病毒(HAdVs)在内的呼吸道病毒是导致儿童下呼吸道感染的常见原因。本综述旨在阐明非洲儿童腺病毒呼吸道感染的流行病学、临床表现、后遗症和治疗方案:最近的研究结果:最近的证据对认为腺病毒是可忽略不计的 LRTIs 病因的看法提出了质疑。研究表明,在非洲低收入和中等收入国家的 5 岁以下儿童致命性肺炎中,HAdV 已成为第三大最常见的病毒病原体,占所有肺炎死亡病例的 5.5%,在医院相关病毒性肺炎死亡病例中排名第二。与疾病相关的主要 HAdV 血清型因国家和地区而异,并随着时间的推移而发生变化。摘要:尽管包括 HAdV 在内的呼吸道病毒是公认的 LRTIs 的致病因素,但人们对腺病毒感染的发病率和影响却认识不足,并低估了其影响。现有数据表明,非洲儿童,尤其是 5 岁以下儿童,有可能因呼吸道 HAdV 感染而留下严重后遗症。包括支气管扩张和感染后阻塞性支气管炎在内的长期后遗症进一步凸显了 HAdV 感染的重大影响。然而,由于缺乏全面的数据,我们无法了解 HAdV 感染对非洲儿童肺部健康的影响程度。我们建议扩大 HAdV 监测范围,确保将其持续纳入人口层面的 LRTI 评估,并扩大和公平地提供诊断服务,以便及早识别面临慢性后遗症和死亡风险的非洲儿童。加强对腺病毒流行病学和临床结果的了解以及提供治疗方案对于制定知情的公共卫生战略和临床护理至关重要。
{"title":"Respiratory adenovirus infections in children: a focus on Africa.","authors":"Marieke M van der Zalm, Nadia A Sam-Agudu, Lilly M Verhagen","doi":"10.1097/MOP.0000000000001335","DOIUrl":"10.1097/MOP.0000000000001335","url":null,"abstract":"<p><strong>Purpose of review: </strong>Lower respiratory tract infections (LRTIs) are an important cause of child morbidity and mortality globally, especially in children under the age of 5 years in Africa. Respiratory viruses, including human adenoviruses (HAdVs), are common causes of LRTIs in children. This review aims to shed light on the epidemiology, clinical manifestations, sequelae, and treatment options specific to adenovirus respiratory infections in African children.</p><p><strong>Recent findings: </strong>Recent evidence has challenged the perception that adenovirus is a negligible cause of LRTIs. Studies show HAdV emerging as the third most common viral pathogen in fatal pneumonias among under-5 children in low-income and middle-income African countries, contributing to 5.5% of all pneumonia deaths and ranking second in hospital-associated viral pneumonia deaths. Predominant HAdV serotypes associated with disease differ by country and region, and have changed over time. Risk factors for increased disease severity and long-term respiratory sequelae in previously healthy African children with HAdV LRTIs are not well established.</p><p><strong>Summary: </strong>Although respiratory viruses, including HAdV, are recognized contributors to LRTIs, the prevalence and impact of adenovirus infections have been under-recognized and understated. Available data suggests that African children, particularly those under 5 years old, are at risk of severe sequelae from respiratory HAdV infections. Long-term sequelae, including bronchiectasis and postinfectious bronchiolitis obliterans, further underscore the significant impact of HAdV infections. However, the scarcity of comprehensive data hampers our understanding of the extent of the impact of HAdV infections on child lung health in Africa. We recommend scaled-up HAdV surveillance, ensuring its consistent inclusion in population-level LRTI assessments, and expanded and equitable access to diagnostics for early recognition of African children at risk of developing chronic sequelae and death. Enhanced understanding of adenovirus epidemiology and clinical outcomes and the availability of therapeutic options are essential for informed public health strategies and clinical care.</p>","PeriodicalId":10985,"journal":{"name":"Current opinion in pediatrics","volume":null,"pages":null},"PeriodicalIF":3.6,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11062604/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140093608","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Caring for screenagers (part 2): a pediatrician's primer on popular games and educational tools. 关爱屏幕少年(第二部分):儿科医生关于流行游戏和教育工具的入门读物。
IF 2.2 3区 医学 Q1 Medicine Pub Date : 2024-06-01 Epub Date: 2024-03-05 DOI: 10.1097/MOP.0000000000001341
Alex Margolis, Joseph Barile, Grace Cason, Ruth Milanaik

Purpose of review: The internet has changed the way children can work and play. With the preferences of the youth population constantly evolving, it is important that parents and pediatricians continue to be informed of the ways children spend their time on the internet. Online gaming continues to soar in popularity, as does school usage of educational platforms.

Recent findings: Roblox, Fortnite, and Minecraft are three examples of games that have widespread popularity among youth populations. Though none of the game are designed to display graphic violence, sexual content, or other features that could be considered off-limits for children, there still ways for children to exposed to inappropriate material or engage with strangers. The rise in popularity of eSports also reflects changing attitudes about the value of gaming. On the educational side, school-student platforms and powerful artificial intelligence (AI) tools are becoming more and more prevalent.

Summary: Parents should not simply know which games or educational tools their children are using, but understand them. This article seeks to provide some insight into popular games and platforms so that parents and pediatricians can make better decisions about what children access.

审查目的:互联网改变了儿童工作和娱乐的方式。随着青少年的喜好不断变化,家长和儿科医生必须继续了解儿童在互联网上消磨时间的方式。网络游戏继续大受欢迎,学校对教育平台的使用也是如此:Roblox、Fortnite 和 Minecraft 是在青少年群体中广为流行的三款游戏。虽然这些游戏在设计上都没有显示暴力画面、性内容或其他可能被视为儿童禁区的功能,但儿童仍有机会接触到不适当的材料或与陌生人接触。电子竞技的流行也反映了人们对游戏价值态度的变化。在教育方面,学校-学生平台和强大的人工智能(AI)工具正变得越来越普遍。摘要:家长不应该仅仅知道孩子在使用哪些游戏或教育工具,还应该了解它们。本文旨在提供一些关于流行游戏和平台的见解,以便家长和儿科医生能更好地决定儿童使用哪些游戏和平台。
{"title":"Caring for screenagers (part 2): a pediatrician's primer on popular games and educational tools.","authors":"Alex Margolis, Joseph Barile, Grace Cason, Ruth Milanaik","doi":"10.1097/MOP.0000000000001341","DOIUrl":"10.1097/MOP.0000000000001341","url":null,"abstract":"<p><strong>Purpose of review: </strong>The internet has changed the way children can work and play. With the preferences of the youth population constantly evolving, it is important that parents and pediatricians continue to be informed of the ways children spend their time on the internet. Online gaming continues to soar in popularity, as does school usage of educational platforms.</p><p><strong>Recent findings: </strong>Roblox, Fortnite, and Minecraft are three examples of games that have widespread popularity among youth populations. Though none of the game are designed to display graphic violence, sexual content, or other features that could be considered off-limits for children, there still ways for children to exposed to inappropriate material or engage with strangers. The rise in popularity of eSports also reflects changing attitudes about the value of gaming. On the educational side, school-student platforms and powerful artificial intelligence (AI) tools are becoming more and more prevalent.</p><p><strong>Summary: </strong>Parents should not simply know which games or educational tools their children are using, but understand them. This article seeks to provide some insight into popular games and platforms so that parents and pediatricians can make better decisions about what children access.</p>","PeriodicalId":10985,"journal":{"name":"Current opinion in pediatrics","volume":null,"pages":null},"PeriodicalIF":2.2,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140038922","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Updates on respiratory syncytial virus prophylaxis: the past, present and future. 呼吸道合胞病毒预防的最新进展:过去、现在和未来。
IF 3.6 3区 医学 Q1 Medicine Pub Date : 2024-06-01 Epub Date: 2024-02-13 DOI: 10.1097/MOP.0000000000001339
Anne Coates, Christy Sadreameli

Purpose of review: Human respiratory syncytial virus (RSV) causes acute respiratory infection in individuals of all age groups. It is the most common pathogen identified in infants and young children with acute lower respiratory infection. Although most infants and young children experience mild, cold-like symptoms, some infants develop severe lower respiratory tract disease such as pneumonia and bronchiolitis that may result in an emergency department visit or hospitalization.

Recent findings: In the United States, hospitalization rates have risen during the last decades, and while premature infants with chronic lung disease and congenital heart disease are at increased risk for severe presentations, the majority of hospitalizations occur in previously healthy infants. Until recently, RSV prophylaxis was only available for former preterm infants and those with certain underlying medical conditions.

Summary: The need for preventive interventions against RSV is crucial. This paper will provide a review of the vaccine development, the spectrum of RSV prophylaxis, current challenges associated with the cost, insurance coverage and equitable distribution of targeted therapies.

审查目的:人类呼吸道合胞病毒(RSV)会导致各个年龄段的人发生急性呼吸道感染。它是婴幼儿急性下呼吸道感染中最常见的病原体。虽然大多数婴幼儿会出现轻微的类似感冒的症状,但有些婴儿会发展成严重的下呼吸道疾病,如肺炎和支气管炎,可能导致急诊就诊或住院治疗:在美国,住院率在过去几十年中有所上升,虽然患有慢性肺病和先天性心脏病的早产儿出现严重症状的风险增加,但大多数住院病例发生在以前健康的婴儿身上。直到最近,RSV 预防性治疗仅适用于以前的早产儿和患有某些潜在疾病的婴儿。本文将回顾疫苗的开发、RSV 预防治疗的范围、目前与成本、保险范围和公平分配靶向疗法相关的挑战。
{"title":"Updates on respiratory syncytial virus prophylaxis: the past, present and future.","authors":"Anne Coates, Christy Sadreameli","doi":"10.1097/MOP.0000000000001339","DOIUrl":"10.1097/MOP.0000000000001339","url":null,"abstract":"<p><strong>Purpose of review: </strong>Human respiratory syncytial virus (RSV) causes acute respiratory infection in individuals of all age groups. It is the most common pathogen identified in infants and young children with acute lower respiratory infection. Although most infants and young children experience mild, cold-like symptoms, some infants develop severe lower respiratory tract disease such as pneumonia and bronchiolitis that may result in an emergency department visit or hospitalization.</p><p><strong>Recent findings: </strong>In the United States, hospitalization rates have risen during the last decades, and while premature infants with chronic lung disease and congenital heart disease are at increased risk for severe presentations, the majority of hospitalizations occur in previously healthy infants. Until recently, RSV prophylaxis was only available for former preterm infants and those with certain underlying medical conditions.</p><p><strong>Summary: </strong>The need for preventive interventions against RSV is crucial. This paper will provide a review of the vaccine development, the spectrum of RSV prophylaxis, current challenges associated with the cost, insurance coverage and equitable distribution of targeted therapies.</p>","PeriodicalId":10985,"journal":{"name":"Current opinion in pediatrics","volume":null,"pages":null},"PeriodicalIF":3.6,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139729195","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Updates on the clinical integration of point-of-care ultrasound in pediatric emergency medicine. 儿科急诊医学中床边超声临床整合的最新进展。
IF 3.6 3区 医学 Q1 Medicine Pub Date : 2024-06-01 Epub Date: 2024-02-23 DOI: 10.1097/MOP.0000000000001340
Michelle Sin Lee, Danielle Sweetnam-Holmes, Gili Palnizky Soffer, Maya Harel-Sterling

Purpose of review: There is expanding evidence for point-of-care ultrasound (POCUS) use in pediatric emergency medicine - this review highlights the benefits and challenges in the clinical integration of high-yield POCUS applications. Specifically, it will delve into POCUS applications during resuscitations, controversies of Focused Assessment with Sonography for Trauma (FAST) in pediatric trauma, POCUS-guided procedures, and examples of clinical pathways where POCUS can expedite definitive care.

Recent findings: POCUS can enhance diagnostic accuracy and aid in management of pediatric patients in shock and help identify reversible causes during cardiac arrest. The use of the FAST in pediatric blunt abdominal trauma remains nuanced - its proper use requires an integration with clinical findings and an appreciation of its limitations. POCUS has been shown to enhance safety and efficacy of procedures such as nerve blocks, incision & drainage, and intravenous access. Integrating POCUS into pathways for conditions such as intussusception and testicular torsion expedites downstream care.

Summary: POCUS enhances diagnostic efficiency and management in pediatric patients arriving at the ED with undifferentiated shock, cardiac arrest, or trauma. Additionally, POCUS improves procedural success and safety, and is integral to clinical pathways for expediting definitive care for various pediatric emergencies. Future research should continue to focus on the impact of POCUS on patient outcomes, ensuring user competency, and the expansion of POCUS into diverse settings.

综述目的:在儿科急诊医学中使用床旁超声(POCUS)的证据越来越多--本综述强调了临床整合高产POCUS应用的益处和挑战。具体而言,该综述将深入探讨复苏过程中的 POCUS 应用、创伤超声聚焦评估(FAST)在儿科创伤中的争议、POCUS 引导下的手术以及 POCUS 可加快确定性护理的临床路径示例:POCUS 可提高诊断准确性,帮助管理休克的儿科患者,并有助于识别心脏骤停时的可逆原因。在小儿腹部钝性创伤中使用 FAST 仍有细微差别--其正确使用需要结合临床发现并了解其局限性。实践证明,POCUS 可提高神经阻滞、切开引流和静脉通路等手术的安全性和有效性。将 POCUS 纳入肠套叠和睾丸扭转等疾病的治疗路径可加快下游护理的进程。摘要:POCUS 可提高诊断效率,并改善因未分化休克、心脏骤停或外伤而到达急诊室的儿科患者的管理。此外,POCUS 还能提高手术的成功率和安全性,是加快各种儿科急症最终治疗的临床路径中不可或缺的一部分。未来的研究应继续关注 POCUS 对患者预后的影响、确保使用者的能力以及将 POCUS 推广到各种环境中。
{"title":"Updates on the clinical integration of point-of-care ultrasound in pediatric emergency medicine.","authors":"Michelle Sin Lee, Danielle Sweetnam-Holmes, Gili Palnizky Soffer, Maya Harel-Sterling","doi":"10.1097/MOP.0000000000001340","DOIUrl":"10.1097/MOP.0000000000001340","url":null,"abstract":"<p><strong>Purpose of review: </strong>There is expanding evidence for point-of-care ultrasound (POCUS) use in pediatric emergency medicine - this review highlights the benefits and challenges in the clinical integration of high-yield POCUS applications. Specifically, it will delve into POCUS applications during resuscitations, controversies of Focused Assessment with Sonography for Trauma (FAST) in pediatric trauma, POCUS-guided procedures, and examples of clinical pathways where POCUS can expedite definitive care.</p><p><strong>Recent findings: </strong>POCUS can enhance diagnostic accuracy and aid in management of pediatric patients in shock and help identify reversible causes during cardiac arrest. The use of the FAST in pediatric blunt abdominal trauma remains nuanced - its proper use requires an integration with clinical findings and an appreciation of its limitations. POCUS has been shown to enhance safety and efficacy of procedures such as nerve blocks, incision & drainage, and intravenous access. Integrating POCUS into pathways for conditions such as intussusception and testicular torsion expedites downstream care.</p><p><strong>Summary: </strong>POCUS enhances diagnostic efficiency and management in pediatric patients arriving at the ED with undifferentiated shock, cardiac arrest, or trauma. Additionally, POCUS improves procedural success and safety, and is integral to clinical pathways for expediting definitive care for various pediatric emergencies. Future research should continue to focus on the impact of POCUS on patient outcomes, ensuring user competency, and the expansion of POCUS into diverse settings.</p>","PeriodicalId":10985,"journal":{"name":"Current opinion in pediatrics","volume":null,"pages":null},"PeriodicalIF":3.6,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139971330","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Current opinion in pediatrics
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1